Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR–ABL kinase inhibition
暂无分享,去创建一个
P. Šimara | L. Tesarová | S. Stejskal | I. Koutná | Z. Zdráhal | J. Mayer | D. Potěšil | M. Potěšilová | Michaela Potěšilová